Sichuan Cancer Hospital & Institute — Chengdu
JCI-accredited cancer specialist hospital — proton therapy, CAR-T, and advanced radiotherapy in western China
Founded
1979
Beds
1,590
Location
Chengdu
About Sichuan Cancer
Sichuan Cancer Hospital & Institute is western China's premier specialist oncology institution — Grade 3A, JCI accredited, and home to the region's most advanced radiotherapy programme, including brachytherapy (the largest centre in western China) and proton therapy infrastructure. Founded in 1979, it has 1,590 beds dedicated entirely to cancer care, and a clinical profile spanning 40 departments. It has international research partnerships with institutions in the US, Europe, and the Asia-Pacific, and is where western China's first internal CAR-T cell therapy treatment was conducted.
Why International Patients Choose Sichuan Cancer
- ✓Western China's most advanced radiation oncology centre — brachytherapy (largest in western China) and proton therapy infrastructure
- ✓JCI accredited — the international quality standard recognised by most European health insurers for overseas oncology claims
- ✓First CAR-T cell therapy in western China administered here — active immunotherapy programme treating relapsed blood cancers
- ✓All 1,590 beds dedicated exclusively to oncology — concentrated specialist expertise across 40 cancer-specific departments
- ✓International research partnerships with US, European, and Asia-Pacific cancer institutions — patients may access clinical trials unavailable in Europe
Specialties
Explore related treatment guides:
Accreditations & Standards
Grade 3A is China's highest hospital classification, awarded to institutions meeting the most rigorous standards in clinical quality, staffing, infrastructure, and patient safety. JCI accreditation adds an internationally recognised layer of certification accepted by most European insurers.
Getting There
Frequently Asked Questions
What is proton therapy and why is it significant at Sichuan Cancer Hospital?
Proton therapy is the most precise form of radiation treatment — it delivers a targeted dose to the tumour while minimising damage to surrounding healthy tissue. It is particularly valuable for head and neck cancers, brain tumours, paediatric cancers, and prostate cancer. Sichuan Cancer Hospital has proton therapy infrastructure in its Tianfu Campus development, and waiting times are typically shorter than in Europe, where proton therapy centres often have 6–12 month waits.
What blood cancer treatments does Sichuan Cancer Hospital offer?
Sichuan Cancer Hospital conducted western China's first internal CAR-T cell therapy treatment. Its haematological oncology programme covers CAR-T immunotherapy for relapsed or refractory B-cell lymphoma and multiple myeloma, as well as chemotherapy and stem cell transplantation protocols. International patients who have not responded to first-line therapy in Europe may be eligible for CAR-T assessment.
Can I combine treatment at both Sichuan Cancer Hospital and West China Hospital?
Yes. Both hospitals are located in Chengdu's Wuhou District, approximately 15 minutes apart. For complex cases where surgical resection at West China Hospital is followed by specialist radiation therapy at Sichuan Cancer Hospital — or vice versa — our coordinators can arrange sequential treatment planning across both institutions in a single extended visit.
Does Sichuan Cancer Hospital accept international health insurance?
As a JCI-accredited institution, Sichuan Cancer Hospital's international patient services work with select international insurers. Most European health insurance policies covering overseas treatment recognise JCI accreditation as the quality standard. Our coordinators can advise on pre-authorisation documentation and direct billing arrangements.
Get a Free Treatment Assessment
Submit your case details and receive a personalised plan within 24 hours — including hospital recommendation, cost estimate, and next steps.